SCHEMBL14009119

SCHEMBL14009119

O=C(Nc1ccc(-n2cncn2)cc1)c1ccc(C(=O)NC2CCCCC2)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMYD3 Q9H7B4 1/20 0.48
▸ HPGD P15428 4/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ TSHR P16473 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ ESR1 P03372 1/20 0.43
▸ ESRRG P62508 1/20 0.43
▸ ESR2 Q92731 1/20 0.43
▸ PTPN1 P18031 1/20 0.43
▸ PTPN11 Q06124 1/20 0.43
▸ S1PR1 P21453 1/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ ROCK1 Q13464 1/20 0.41
▸ CTSL P07711 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009095 0.99 SMYD3 (0.49) SMYD3HPGDALDH1A1RAB9ATSHR
SCHEMBL14009091 0.97 SMYD3 (0.49) SMYD3HPGDALDH1A1RAB9ATSHR
SCHEMBL14009108 0.95 SMYD3 (0.53) SMYD3HPGDALDH1A1RAB9ASMN1; SMN2
SCHEMBL14009189 0.90 SMYD3 (0.47) SMYD3HPGDALDH1A1SMN1; SMN2S1PR1
SCHEMBL14009180 0.89 SMYD3 (0.46) SMYD3RAB9ASMN1; SMN2NPC1S1PR1
SCHEMBL14009112 0.88 SMYD3 (0.46) SMYD3HPGDALDH1A1RAB9ANPC1
SCHEMBL14009160 0.86 SMYD3 (0.43) SMYD3S1PR1ROCK1CTSLCTSS
SCHEMBL14009200 0.86 SMYD3 (0.43) SMYD3S1PR1ROCK1SYKCCR3
SCHEMBL14009164 0.85 SMYD3 (0.45) SMYD3RAB9ANPC1S1PR1RXFP1
SCHEMBL14009128 0.85 HDAC3 (0.50) SMYD3RAB9ANPC1S1PR1ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
WO-2007022258-A1 NOVEL HIGH AFFINITY THIOPHENE-BASED AND FURAN-BASED KINASE LIGANDS SCHERING CORPORATION (US) 2007-02-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands CDKL2, CDK2, CDKL1 SMYD3 3202/4885HPGD 1636/4885ALDH1A1 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback